首页> 外文期刊>World Journal of Urology >Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine
【24h】

Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine

机译:大鼠肾脏缺血模型中的低氧预处理:对肼苯哒嗪使用的评估

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction With the advent of improved diagnostic and imaging techniques, it is now possible to detect renal cancers in their very early stages, when they are still present as small renal masses. In these situations, use of laparoscopic partial nephrectomy (LPN) techniques are indicated and have gained acceptance in major medical institutions worldwide, offering comparable oncological outcomes and improving quality of life in the patient when contrasted with open nephrectomy procedures. However, a complication that may occur during or after this surgery is the possibility of compromising renal function, as a result of extended ischemia times of more than 30 min. We have undertaken a systematic study of the potential of several agents that may enhance renal parenchymal preservation without causing unwanted renal dysfunction as a result of enhanced ischemia times. In this study, we have evaluated the potential of one such agent under study, namely hydralazine, which was shown earlier to enhance hypoxia inducible factor-1α (HIF-1α) levels in experimental animal systems. Our aim was to determine whether enhanced levels of HIF-1α via pre-treatment with hydralazine had a reno-protective effect after ischemic injury.
机译:简介随着改进的诊断和成像技术的出现,现在有可能在早期阶段检测肾脏癌,那时它们仍以小的肾脏块存在。在这种情况下,腹腔镜部分肾切除术(LPN)技术的使用已被指出,并已获得全球主要医疗机构的接受,与开放式肾切除术相比,它具有可比的肿瘤学结果并改善了患者的生活质量。但是,由于延长的缺血时间超过30分钟,因此可能在手术期间或之后发生并发症,损害肾功能。我们已经对几种药物的潜力进行了系统的研究,这些药物可能会增强肾脏实质的保存,而不会由于缺血时间的延长而引起不必要的肾功能障碍。在这项研究中,我们评估了一种正在研究中的药物肼苯哒嗪的潜力,该化合物在早期被证明可以增强实验动物系统中的缺氧诱导因子-1α(HIF-1α)水平。我们的目的是确定通过用肼屈嗪预处理提高的HIF-1α水平是否具有缺血损伤后的肾脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号